
|Articles|October 1, 2012
Cell-based therapy holds promise for venous leg ulcers
A first-in-class cell-based therapy holds promise for better treatment of chronic venous ulcers. Surprisingly, the less intense regimen - fewer cells, administered less often - proved to be the more effective of the options studied, according to results published online Aug. 2 in The Lancet.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
2
FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA
3
Kyowa Kirin Takes Full Control of Rocatinlimab Program
4
Dermatology Times January 2026 Recap
5











